Skip to main content

Surgery News (Page 11)

Most Patients With Stage I PDAC Are Upstaged on Histopathology

MONDAY, Sept. 9, 2024 – More than 70 percent of patients with stage I pancreatic ductal adenocarcinoma (PDAC) and close to 30 percent with stage II PDAC are upstaged on histopathology, according to...

Machine Learning Can ID Risk for Persistent Opioid Use After Surgery

FRIDAY, Sept. 6, 2024 – Machine learning can identify patients who are at risk for persistent opioid use after surgery, according to a study published in the September issue of Plastic and...

Nicotine, Marijuana Use Underreported by Plastic Surgery Patients

WEDNESDAY, Sept. 4, 2024 – Plastic surgery patients who use marijuana also have elevated nicotine levels, according to a study published in the September issue of Plastic and Reconstructive Surgery. ...

Suicide Risk Higher for Cancer Patients Not Proceeding With Recommended Surgery

WEDNESDAY, Sept. 4, 2024 – Higher suicide deaths are seen among cancer patients who do not undergo recommended surgery, according to a research letter published online Sept. 3 in JAMA Network Open. ...

Lower Potassium Threshold After CABG Safe for A-Fib Prevention

WEDNESDAY, Sept. 4, 2024 – Potassium supplementation at a threshold of

New Medical Technology Lights Up Bacteria Hiding in Wounds

FRIDAY, Aug. 30, 2024 – Fluorescent light can be used to highlight bacteria that hides in wounds, causing infections and slowing down the healing process, a new evidence review says. A handheld...

Restrictive Strategy for Gallstone Surgery Does Not Change Five-Year Outcomes

THURSDAY, Aug. 29, 2024 – In patients with abdominal pain and gallstones, a more restrictive approach may avoid unnecessary cholecystectomies, with no difference in five-year outcomes, according to...

It's Safer to Donate a Kidney Now Than at Any Time in History

WEDNESDAY, Aug. 28, 2024 – The risk of death associated with donating a kidney is at an all-time low, a new study finds. A kidney donor’s risk – already small a decade ago – is now lower by more t...

Outcomes Similar for Neoadjuvant ICI-Based Therapy, Upfront Surgery for Liver Cancer

THURSDAY, Aug. 22, 2024 – Patients treated with neoadjuvant immune checkpoint inhibitor (ICI)-based therapy for hepatocellular carcinoma (HCC) have higher-risk disease features but achieve outcomes...

Surgery Effective for Thoracic Ossification of Posterior Longitudinal Ligament

THURSDAY, Aug. 22, 2024 – For patients with thoracic ossification of the posterior longitudinal ligament (T-OPLL), surgical treatment is effective for improving neurological function, quality of...

Study Quantifies COVID-19-Linked Deficit in Arthroplasties in the U.K.

THURSDAY, Aug. 15, 2024 – The COVID-19-induced deficit in arthroplasty procedures is equivalent to 71.6 percent of a year of normal expected operating activity, according to a study published online...

FDA Medwatch Alert: SterRx, LLC Issues Voluntary Nationwide Recall of Certain SterRx Products

SterRx, LLC today announced the voluntary nationwide recall of approximately 240 lots within their expiry period due to equipment and process issues that could lead to a lack of sterility assurance...

FDA Medwatch Alert: FDA Alerts Patients and Health Care Professionals Not to Use Compounded Products Intended to be Sterile from Prescription Labs Inc. dba Greenpark Compounding Pharmacy

September 17, 2021 – FDA is alerting patients and health care professionals not to use compounded products intended to be sterile, produced and distributed nationwide by Prescription Labs Inc. doing...

FDA Approves Posimir (bupivacaine) for Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression

CUPERTINO, Calif., Feb. 2, 2021 /PRNewswire/ – DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration (FDA) has approved Posimir (bupivacaine solution) for...

FDA Approves Doptelet (avatrombopag) for Chronic Liver Disease Patients with Thrombocytopenia who are Undergoing a Medical Procedure

May 21, 2018 – The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are...

Ask a question

To post your own question to our community, sign in or create an account.